Author(s):
Ali Majeed Ali Almukram, Hayder Naji Sameer, Amjad I. Oraibi, Hany A. Al-Hussaniy, Ahmed Hamza Al-Shammari, Zahraa Salam Al-Tameemi, Meena Akeel Naji, Ali HikmatAlburghaif, Fatima A Naji, Maryam Saleem
Email(s):
hany_akeel2000@yahoo.com , ahmadahaa2020@gmail.com
DOI:
10.52711/0974-360X.2024.00929 
Address:
Ali Majeed Ali Almukram1, Hayder Naji Sameer2, Amjad I. Oraibi3, Hany A. Al-Hussaniy4,5*, Ahmed Hamza Al-Shammari6*, Zahraa Salam Al-Tameemi5,
Meena Akeel Naji5, Ali HikmatAlburghaif6, Fatima A Naji5, Maryam Saleem8
1Pharmacy School, University of Maryland, Baltimore, US.
2Collage of Pharmacy, Department of Clinical Pharmacy, National University of Science and Technology, DhiQar, Iraq.
3Department of Pharmacy, Al-Manara College for Medical Sciences, Amarah, Iraq.
4Department of Pharmacology, College of Medicine, University of Baghdad, Baghdad, Iraq.
5Dr. Hany Akeel Institute, Iraqi Medical Research Center, Baghdad, Iraq.
6Department of Pharmacy, Kut University College, Alkut, Wasit, 52001, Iraq.
7Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq.
8Department of Pharmacy, Al-turath University, Baghdad, Iraq.
*Corresponding Author
Published In:
Volume - 17,
Issue - 12,
Year - 2024
ABSTRACT:
Background: Acute myeloid leukemia (AML) is a heterogeneous malignancy principally affecting the elderly population. Despite advances regarding molecular dissection of the disease, prognosis remains poor, with an overall survival of less than 30%. Current treatment for patients with newly diagnosed AML usually includes intensive chemotherapy treatment or allogeneic hematopoietic stem cell transplantationAim:Our review aims to provide an overview of T cell responses in AML, including the role of T cells in immune surveillance, tumour immunosuppression, and emerging immunotherapeutic approaches targeting T cell responses in AML. Method: A comprehensive review of the literature was conducted to identify studies investigating T cell responses in AML. Key findings from preclinical models, clinical trials, and translational research were synthesized to elucidate the mechanisms underlying T cell-mediated immunity in AML and its implications for therapeutic intervention. Result: T cells play a critical role in immune surveillance against AML cells through the recognition and elimination of leukaemic antigens presented on the surface of malignant cells. However, AML cells employ various mechanisms to evade immune detection and suppress T cell-mediated responses, including downregulation of antigen presentation, upregulation of immune checkpoint molecules, and recruitment of immunosuppressive cell populations such as regulatory T cells and myeloid-derived suppressor cells. Despite these challenges, emerging immunotherapeutic strategies aimed at enhancing T cell responses in AML, such as chimeric antigen receptor (CAR) T cell therapy, bispecific T cell engagers (BiTEs), and immune checkpoint blockade, hold promise for improving outcomes in AML patients. Conclusion: Currently, standard treatment consists of chemotherapy but only a subset of AML patients responds, and those achieving complete remission often relapse. There is a great need for new, more effective therapies, and immunotherapy is one of the most promising alternatives. T cells are major players for an effective immune response to cancer, but their functionality is often compromised by various, including cancer evasion strategies, thus enhancing the need for understanding the T cell compartment in this disease
Cite this article:
Ali Majeed Ali Almukram, Hayder Naji Sameer, Amjad I. Oraibi, Hany A. Al-Hussaniy, Ahmed Hamza Al-Shammari, Zahraa Salam Al-Tameemi, Meena Akeel Naji, Ali HikmatAlburghaif, Fatima A Naji, Maryam Saleem. T cell Responses to Acute Myeloid Leukaemia: A Review of Current Literature. Research Journal Pharmacy and Technology. 2024;17(12):6125-1. doi: 10.52711/0974-360X.2024.00929
Cite(Electronic):
Ali Majeed Ali Almukram, Hayder Naji Sameer, Amjad I. Oraibi, Hany A. Al-Hussaniy, Ahmed Hamza Al-Shammari, Zahraa Salam Al-Tameemi, Meena Akeel Naji, Ali HikmatAlburghaif, Fatima A Naji, Maryam Saleem. T cell Responses to Acute Myeloid Leukaemia: A Review of Current Literature. Research Journal Pharmacy and Technology. 2024;17(12):6125-1. doi: 10.52711/0974-360X.2024.00929 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-12-66
REFERENCES:
1. DiNardo CD, Erba HP, Freeman SD, Wei AH. Acute myeloid leukaemia. Lancet. 2023; 401(10393): 2073–86. DOI:10.1016/S0140-6736(23)00108-3
2. Al-Allawi N. Kalisikhudair A-, mahersura, najimsuhail. p53 expression in chronic lymphocytic leukaemia. J Fac Med Bagdad. 2003; 47: 126–31.
3. Zhang X, Dong Y, Liu D, Yang L, Xu J, Wang Q. Antigen-specific immunotherapies in type 1 diabetes. J Trace Elem Med Biol. 2022; 73(127040): 127040. DOI:10.1016/j.jtemb.2022.127040
4. Corradi G, Bassani B, Simonetti G, Sangaletti S, Vadakekolathu J, Fontana MC, et al. Release of IFNγ by acute myeloid leukemia cells remodels bone marrow immune microenvironment by inducing regulatory T cells. Clin Cancer Res. 2022; 28(14): 3141–55. DOI:10.1158/1078-0432.CCR-21-3594
5. Yasinska IM, Meyer NH, Schlichtner S, Hussain R, Siligardi G, Casely-Hayford M, et al. Ligand-receptor interactions of galectin-9 and VISTA suppress human T lymphocyte cytotoxic activity. Front Immunol. 2020; 11: 580557. DOI:10.3389/fimmu.2020.580557
6. Daver N, Alotaibi AS, Bücklein V, Subklewe M. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments. Leukemia. 2021; 35(7): 1843–63. DOI:10.1038/s41375-021-01253-x
7. Shaaban SM, Gaber Z, Semary S, Dewidar AM. Impact of Vitamin B12 on outcome of Early Stage Luminal A and B Breast Cancer, single center experience. Medical and Pharmaceutical Journal. 2023; 2(1): 17–27.
8. Daver NG, Maiti A, Kadia TM, Vyas P, Majeti R, Wei AH, et al. TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: Biology, current therapy, and future directions. Cancer Discov. 2022; 12(11): 2516–29. DOI:10.1158/2159-8290.CD-22-0332
9. Al-Hussaniy HA, Hassan AF, Oraibi AI, Al-Juhaishi AM, Naji FA, Al-Tameemi ZS. Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq. Journal of Pharmacy and Bioallied Sciences. 2023; 15(3): 101-6.
10. Harari MB, Parola HR, Hartwell CJ, Riegelman A. Literature searches in systematic reviews and meta-analyses: A review, evaluation, and recommendations. J Vocat Behav. 2020; 118(103377): 103377. DOI:10.1016/j.jvb.2020.103377
11. Al-hussaniy HA, Altalebi RR, Albu-Rghaif AH, Abdul-Amir A-GA. The use of PCR for respiratory virus detection on the diagnosis and treatment decision of respiratory tract infections in Iraq. J Pure ApplMicrobiol. 2022; 16(1): 201–6. DOI:10.22207/jpam.16.1.10
12. Al-Hussaniy HA, Mohammed ZN, Alburghaif AH, Naji MA. Panax ginseng as Antioxidant and Anti-inflammatory to reduce the Cardiotoxicity of Doxorubicin on rat module. Research Journal of Pharmacy and Technology. 2022; 15(10): 4594–600.
13. Li Z, Philip M, Ferrell PB. Alterations of T-cell-mediated immunity in acute myeloid leukemia. Oncogene. 2020; 39(18): 3611–9. DOI:10.1038/s41388-020-1239-y
14. Stroopinsky D, Liegel J, Bhasin M, Cheloni G, Thomas B, Bhasin S, et al. Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T-cell responses in a murine acute myeloid leukemia model. Haematologica. 2021;106(5).
15. Ficht X, Iannacone M. Immune surveillance of the liver by T cells. SciImmunol. 2020; 5(51): eaba2351. DOI:10.1126/sciimmunol.aba2351
16. Li J, Qin B, Huang M, Ma Y, Li D, Li W, et al. Tumor-associated antigens (TAAs) for the serological diagnosis of osteosarcoma. Front Immunol. 2021; 12. DOI:10.3389/fimmu.2021.665106
17. Lu L, Jiang J, Zhan M, Zhang H, Wang Q-T, Sun S-N, et al. Targeting tumor-associated antigens in hepatocellular carcinoma for immunotherapy: Past pitfalls and future strategies. Hepatology. 2021; 73(2): 821–32. DOI:10.1002/hep.31502
18. Lulla PD, Naik S, Vasileiou S, Tzannou I, Watanabe A, Kuvalekar M, et al. Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood, The Journal of the. Vol. 137. American Society of Hematology; 2021.
19. Masoumi J, Jafarzadeh A, Abdolalizadeh J, Khan H, Philippe J, Mirzaei H, et al. Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects. Acta Pharm Sin B. 2021; 11(7): 1721–39. DOI:10.1016/j.apsb.2020.12.015
20. Jwaid DA, Muhsin MM, Shihab, Al-Hussaniy DA. Computational Screening of Roxithromycin against the SARS-CoV-2 (COVID-19) Coronavirus Receptors by Molecular Docking Abdulkader. Advanced Journal of Chemistry, Section A. 2024; 7(4): 477–88.
21. Abdulhamza HM, Farhan MS, Hassan SS, Al-Hussainy HA, Oriabi AI. In silico identification of antiviral compounds for the treatment of chikungunya virus infection: qsar modelling and md simulation analysis Abdulhamza. Medicine in Novel Technology and Devices. 2024; 22: 100304.
22. Al-Hussaniy HA, Al-Samydai A, Abu Hajleh MN, Mayyas A, I. Oraibi A. Selection and Progress of drugs for treating Dementia. Res J Pharm Technol. 2024; 1674–8. DOI:10.52711/0974-360x.2024.00265
23. Reyadh AS, Shareef AR, Al-Hussaniy, Naji HA. Increasing Prevalence of Congenital Hypothyroidism in children with Down Syndrome who have a family history of Thyroid disease Mahmood. Research Journal of Pharmacy and Technology. 2023; (3): 1327–32.
24. Al-Hussaniy H, Sameer AH, Oraibi HN. The relationship between statin therapy and adipocytokine/inflammatory mediators in dyslipidemic nondiabetic patients: A comparative study. Pharmacia. 2023; 70: 581–5.
25. Wijaya MG, Prahasanti C, Laksono BD, Agrawanty W, Kusumawardhani B, Anggakusuma MJ. Viability Test of Hydroxyapatite Tooth Graft on Osteoblast cell culture. Research Journal of Pharmacy and Technology. 2024; 17(2): 855–9.
26. Krishnamurthy R, Rajagopal A, Subashini R, Harshni V, Shruthi PS. Comparative Study of 3T3 Fibroblast cells grown in the normal and increased glucose conditions under the influence of Aloe vera and Costuspictus. Research Journal of Pharmacy and Technology. 2023; 16(11): 5271-8.
27. Kusmiati M, Nurpalah R, Sukmawan YP, Aryantha I, Gusdinar T. Pharmacological activity of the Ethanolic extract of Lingzhi to the Immune system. Research Journal of Pharmacy and Technology. 2023; 16(10): 4907–10.
28. Wuragil DK, Soeatmadji DW, Rudijanto A, Endharti AT, Aulanni. Development a New Diagnostic Based on Autoimmune Markers for Hashimoto Thyroiditis. Research Journal of Pharmacy and Technology. 2023; 16(12): 6002–7.
29. Zamil AH, Amin SS. Cutoff Point Measurement of the waist circumference for the diagnosis of Metabolic Syndrome in Iraqi university students. Research Journal of Pharmacy and Technology. 2024; 17(1): 127–30.
30. Ibrahim WA, Hassan EA, Ws A-Z. Characterization of Structural, Antimicrobial Activity, of Coriander Seed Oil. Research Journal of Pharmacy and Technology. 2024; 17(1): 265–70.
31. Alkareem A, Hi A-Q, Salman FS. Metformin and Omega 3 effect on Cholesterol and HDL level in Iraqi women with Poly Cystic Ovary Syndrome. Research Journal of Pharmacy and Technology. 2024; 17(1): 385–8.
32. Naji GH, Al Gawhari FJ. Evaluation of types and concentration of bile salts impact on physical properties of nisoldipine-loaded bilosomes. Pharmacia. 2024; 71: 1–7. DOI:10.3897/pharmacia.71.e116917
33. Kamal AK, Talib WH. Combination of ketogenic diet and probiotics inhibits breast cancer in mice by immune system modulation and reduction of Insulin growth factor-1. Pharmacia. 2023; 70: 1411–22.
34. Kaicker A. Immune cells at the maternal-fetal interphase: Role in implantation and establishment of tolerance. Journal of Applied Biology and Biotechnology. 2023; 11(Issue): 45-50.
35. Sangavi D, Anisha PS, Shyu DJH, Thiruchenthil Nathan P. Antimicrobial potential of Indian cooperative spider, Stegodyphussarasinorum, and Golden orb spider, Nephilapilipes hemolymph against pathogenic bacteria. J ApplBiolBiotechnol. 2023; DOI:10.7324/jabb.2023.132509
36. Prashanth J, Manjunatha HB. Transaminases activity in the hemolymph: Biomarkers determining the thermal stress in the new bivoltine lines of Bombyxmori. J Appl Biol Biotechnol. 2022; DOI:10.7324/jabb.2023.110213
37. Jash R, Maparu K, Seksaria S, Banerjee S, Prasanth DSNBK, Maji HS. Phytomolecules against inflammation and fibrosis in immunoglobulin A nephropathy. J Appl Biol Biotechnol. 2023; DOI:10.7324/jabb.2024.150003
38. Kaicker A. Immune cells at the maternal-fetal interphase: Role in implantation and establishment of tolerance. J Appl Biol Biotechnol. 2023; 11(6): 45–50. DOI:10.7324/jabb.2023.99982
39. Klauer LK, Schutti O, Ugur S, Doraneh-Gard F, Amberger DC, Rogers N, et al. Interferon gamma secretion of adaptive and innate immune cells as a parameter to describe leukaemia-derived dendritic-cell-mediated immune responses in acute myeloid leukaemia in vitro. Transfus Med Hemother. 2022; 49(1): 44–61. DOI:10.1159/000516886
40. Jwaid MM, Alwan MJ, Ihsan I, Jwaid MM, Muhsin YF, Al-hussaniy HA. Novel anticoagulants in the management of atrial fibrillation: a comprehensive comparative analysis. Pharmacia. 2024; 71: 1-6. DOI: 10.3897/pharmacia.71.e113097
41. Tiziani S, Lodi A, Khanim FL, Viant MR, Bunce CM, Günther UL. Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines. PLoSOne. 2009; 4(1): e4251. DOI:10.1371/journal.pone.0004251
42. Kumar A, Singh K, Kumar K, Singh A, Tripathi A, Tiwari L. Drug resistance in cancer therapy: Mechanisms, challenges and strategies. Asian J NursEducRes. 2024; 95–100. DOI:10.52711/2349-2996.2024.00019
43. Dash RK, Sarangi D, Swain RK, Behera S. Liposome a Nanotechnological benefactor to the field of Medicine and Drug delivery. Asian Journal of Pharmacy and Technology. 2022; 12(4): 361–4.
44. Rahul D. Review on Car-T Cell Therapy for Cancer Treatment. International Journal of Technology. 2023; 13(1): 68–70.
45. Ganbarjeddi S, Azimi A, Heydarabad MZ, Hemmatzadeh M, Mohammadi S, Ardehaie RM, Zamani M, Baharaghdam S, Esmaeili S, Ghasemi A. Apoptosis induced by prednisolone occurs without altering the promoter methylation of BAX and BCL-2 genes in acute lymphoblastic leukemia cells CCRF-CEM. Asian Pacific Journal of Cancer Prevention:.2020; 21(2): 523.
46. Al-Hussaniy HA, Al-Zobaidy MJ. Effects of Mdm2 Inhibitors on Cellular Viability of Breast Cancer Cell Lines HP100, MCF7. Bratislava Medical Journal. 2024; 125(10): 627–34.
47. AL-Zobaidy MJ, Akeel Al-Hussaniy H, S. Al-tameemi Z. In silico comparison between the mutated and wild-type androgen receptors and their influence on the selection of optimum androgenic receptor blockers for the treatment of prostate cancer. F1000Research. 2024; 11: 516.
48. Salim Mahmood A, Ammoo AM, Ali MH, Hameed TM, Al-Hussaniy HA, Aljumaili AA, Al-Fallooji MH, Kadhim AH. Antiepileptic Effect of Neuroaid® on Strychnine-Induced Convulsions in Mice. Pharmaceuticals. 2022;15(12):1468.
49. Awad M, Al-Hussaniy HA, Alburghaif AH, Tawfeeq KT. The role of COVID-19 in myopathy: incidence, causes, treatment, and prevention. Journal of Medicine and Life. 2022; Dec; 15(12): 1458
50. Al-hussaniy HA, AL-Zobaidy MJ. Cytotoxic Effect of YH239-EE and Its Enantiomer on MCF7 Cell Line. Asian Pacific Journal of Cancer Prevention. 2024; 25: 253–8.
51. Vajari MK, Ehsan M, Ghiasi S, Fooladi S, Karami N, Hassanshahi G, et al. Human Leukocyte Antigen Alleles (HLA-A, HLA-B, and HLA-DRB1) are associated with Acute Lymphoblastic Leukemia (ALL): A Case-Control Study in a Sample of Iranian Population. Asian Pacific Journal of Cancer Prevention. 2024; 25: 1507–13.